JP2023548560A5 - - Google Patents

Info

Publication number
JP2023548560A5
JP2023548560A5 JP2023527041A JP2023527041A JP2023548560A5 JP 2023548560 A5 JP2023548560 A5 JP 2023548560A5 JP 2023527041 A JP2023527041 A JP 2023527041A JP 2023527041 A JP2023527041 A JP 2023527041A JP 2023548560 A5 JP2023548560 A5 JP 2023548560A5
Authority
JP
Japan
Prior art keywords
bases
cells
actuator portion
item
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023527041A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023548560A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/058331 external-priority patent/WO2022099069A1/en
Publication of JP2023548560A publication Critical patent/JP2023548560A/ja
Publication of JP2023548560A5 publication Critical patent/JP2023548560A5/ja
Pending legal-status Critical Current

Links

JP2023527041A 2020-11-08 2021-11-05 遺伝子の発現または活性を調節するための系および方法 Pending JP2023548560A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063111053P 2020-11-08 2020-11-08
US63/111,053 2020-11-08
US202163216659P 2021-06-30 2021-06-30
US63/216,659 2021-06-30
PCT/US2021/058331 WO2022099069A1 (en) 2020-11-08 2021-11-05 Systems and methods for regulating gene expression or activity

Publications (2)

Publication Number Publication Date
JP2023548560A JP2023548560A (ja) 2023-11-17
JP2023548560A5 true JP2023548560A5 (cg-RX-API-DMAC7.html) 2024-10-31

Family

ID=81457425

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023527041A Pending JP2023548560A (ja) 2020-11-08 2021-11-05 遺伝子の発現または活性を調節するための系および方法

Country Status (5)

Country Link
US (1) US20240067991A1 (cg-RX-API-DMAC7.html)
EP (1) EP4240835A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023548560A (cg-RX-API-DMAC7.html)
KR (1) KR20230104264A (cg-RX-API-DMAC7.html)
WO (1) WO2022099069A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026505560A (ja) * 2023-02-09 2026-02-13 フンダサーオ・デー・アンナ・デ・ソマー・シャンパリマウド・エ・ドクター・カルロス・モンテス・シャンパリマウド・ファウンデーション ガンマデルタt細胞受容体を発現する細胞における遺伝子発現の調節
WO2024238691A2 (en) * 2023-05-15 2024-11-21 The Regents Of The University Of California Andp gene editing system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017123559A2 (en) * 2016-01-11 2017-07-20 The Board Of Trustees Of The Leland Stanford Junior University Chimeric proteins and methods of regulating gene expression
JP7012645B2 (ja) * 2016-01-11 2022-01-28 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー キメラタンパク質および免疫治療の方法
WO2019210293A1 (en) * 2018-04-27 2019-10-31 Baylor College Of Medicine Car t cells with one or more interleukins
CN110760480B (zh) * 2019-07-09 2021-07-02 杭州师范大学 一种抗肿瘤nk细胞及其制备方法

Similar Documents

Publication Publication Date Title
Liu et al. The IL-23/IL-17 pathway in inflammatory skin diseases: from bench to bedside
Kamata et al. Crosstalk: keratinocytes and immune cells in psoriasis
Donnelly et al. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes
Li et al. IL-17 receptor–based signaling and implications for disease
Kim et al. IFN-γ up-regulates IL-18 gene expression via IFN consensus sequence-binding protein and activator protein-1 elements in macrophages
Vilček et al. Historical review: cytokines as therapeutics and targets of therapeutics
Donnelly et al. Inhibition of IL-10 expression by IFN-γ up-regulates transcription of TNF-α in human monocytes
Hilkens et al. Differential responses to IFN-α subtypes in human T cells and dendritic cells
Horwood et al. IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro
O'Shea et al. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease
JP2018514199A5 (cg-RX-API-DMAC7.html)
Li et al. Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy
Tighe et al. Gene vaccination: plasmid DNA is more than just a blueprint
Tanaka et al. Cytokine gene regulation: regulatory cis-elements and DNA binding factors involved in the interferon system
Kolls et al. Interleukin-17: an emerging role in lung inflammation
CN103403166B (zh) 新的杂合启动子及包含其的重组载体
JP2018526450A5 (cg-RX-API-DMAC7.html)
JP2020528758A5 (cg-RX-API-DMAC7.html)
Babadei et al. Transcriptional control of interferon-stimulated genes
CA2739902A1 (en) Engineered cells expressing multiple immunomodulators and uses thereof
Joshi et al. Mechanisms of mRNA translation of interferon stimulated genes
Wang et al. Signal transducer and activator of transcription 4 in liver diseases
Yamagata et al. Targeting Th17 effector cytokines for the treatment of autoimmune diseases
JP2013516194A5 (cg-RX-API-DMAC7.html)
Jere et al. Photobiomodulation and the expression of genes related to the JAK/STAT signalling pathway in wounded and diabetic wounded cells